Jan 4, 2020
Hospitals must choose best path forward amid major industry changes
Powerful forces are reshaping the clinical laboratory industry. Deep reimbursement cuts threaten to upend traditional business models. Ongoing commoditization continues to exert margin pressure. Capital requirements are rising as budgets erode. And uncertainty is widespread about how best to manage costly esoteric testing in a value-based world.
by Ben Gold and Don Flott
Ben Gold is CareSelect™ Lab Product Manager at Change Healthcare. Don Flott is Senior Director of Value-Based Medicine at Mayo Clinic Laboratories.